Cytokine-Induced Depression: Current Status and Novel Targets for Depression Therapy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-08 ,pp. : 1066-1074

Bentham Science Publishers

Access to resources Recommend Favorite

Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1819-1835

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Targets for Obesity and Depression: From Serotonin to Leptin

By  

Current Drug Targets, Vol. 17, Iss. 11, 2016-07 ,pp. : 1282-1291

Bentham Science Publishers

Access to resources Recommend Favorite

Neurobiology of Depression and Novel Antidepressant Drug Targets

By  

Current Pharmaceutical Design, Vol. 18, Iss. 36, 2012-12 ,pp. : 5791-5801

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

By Holmes A.   Heilig M.   Rupniak N.M.J.   Steckler T.   Griebel G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 580-588

Elsevier

Access to resources Recommend Favorite